Beijing Cooperate Pharmaceutical

Beijing Cooperate Pharmaceutical is a China-based pharmaceutical company focused on the commercial supply of active pharmaceutical ingredients, pharmaceutical intermediates, and related chemical products. Publicly available company profiles describe it as a high-tech enterprise serving pharmaceutical and advanced materials markets, with products associated with cardiovascular, oncology, psychiatric, and respiratory disease areas. The company appears to operate primarily as a B2B manufacturer and supplier rather than as a clinical-stage drug developer, and it markets a catalog that includes APIs such as apixaban, baricitinib, brexpiprazole, bupropion hydrochloride, lurasidone hydrochloride, pomalidomide, tadalafil, and tofacitinib citrate. Available evidence indicates a Beijing, China base in the Daxing biomedicine industrial area and ongoing commercial activity in API and intermediate supply.